Introduction to pharmaceutical technology

Similar documents
Introduction to Enteris BioPharma

A FDA Perspective on Nanomedicine Current Initiatives in the US

Section II When you are finished with this section, you will be able to: Define medication (p 2) Describe how medications work (p 3)

Overview of Drug Development: the Regulatory Process

ANDA CHECKLIST FOR CTD or ectd FORMAT FOR COMPLETENESS and ACCEPTABILITY of an APPLICATION FOR FILING

ROUTES OF DRUG ADMINISTRATION

Annex 7 Guidelines on pre-approval inspections

Guidance for Industry

Not All Clinical Trials Are Created Equal Understanding the Different Phases

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)

2014 Annual Report on Inspections of Establishments

European Continuing Education College

Importing pharmaceutical products to China

September 19, 1984 FOOD PRODUCTION AND DIRECTION GÉNÉRALE, SECTION INSPECTION BRANCH PRODUCTION ET INSPECTION PESTICIDES DES ALIMENTS TRADE MEMORANDUM

Absorption of Drugs. Transport of a drug from the GI tract

Food, Medicine and Health Care Administration and Control Authority

Post-Approval Change Management: Challenges and Opportunities An FDA Perspective

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S1A. Current Step 4 version

PHARMACEUTICAL EXCIPIENTS

C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to

4.1 Objectives of Clinical Trial Assessment

Pharmacy Technician Training Program. Minimum Competencies

Coventry Health Care of Georgia, Inc. Coventry Health and Life Insurance Company

Study (s) Degree Center Acad. Period Grado de Farmacia FACULTY OF PHARMACY 3 Annual PDG Farmacia-Nutrición Humana y Dietética

Guidance for Industry

For personal use only

400,000 people in the United States die every year due to smoking-related illnesses.

PL 17871/0208 UKPAR TABLE OF CONTENTS

PRODUCT DEVELOPMENT GUIDE

Editorial Calendar 2014

NEW BRUNSWICK GRADUATION REQUIREMENTS PROGRAM OBJECTIVES PROGRAM OVERVIEW CAREER OPPORTUNITIES PREREQUISITES

Nursing 113. Pharmacology Principles

Hybrid or Mixed Marketing Authorization Application in the European Union: Not a Trivial Decision in New Development Programs for Established Drugs

Guidance for Industry

Apply with Resume to: Submenu Path Company/Careers/Current Openings/Job Type: Science

Guidance for Industry

MSc in Toxicology. Master Degree Programme

The Clinical Trials Process an educated patient s guide

ICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals. Step 5

Guidance for Industry. Integration of Dose-Counting Mechanisms into MDI Drug Products

CTC Technology Readiness Levels

Narcotic drugs used for pain treatment Version 4.3

Compilation of individual product-specific guidance on demonstration of bioequivalence

NSW Higher School Certificate Senior Science 9.2 Lifestyle Chemistry

Guidance for Industry

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more:

An integrated global healthcare company

PHARMACEUTICAL MANAGEMENT PROCEDURES

Understanding Our Curriculum

Disclosure. This presentation contains forward-looking statements.

GDUFA Regulatory Science Update

Revised checklist for BA/BE NOC effective from 01 st February 2014 (Draft for comments before 25 Jan 14)

Summary Public Assessment Report. Generics

UNDERSTANDING YOUR HEALTH NET PHARMACY BENEFITS Los Angeles Unified School District Learning about your pharmacy benefits can save you time and money

North-West University. School of Pharmacy. Short Courses: Introductory Guide

A guide for the patient

Drug Development Process

Catalog. Global Education. and Training. Global Expertise Trusted Standards Improved Health

ICH Topic Q 1 A Stability Testing Guidelines: Stability Testing of New Drug Substances and Products

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON HYPERICUM PERFORATUM L., HERBA (TRADITIONAL USE)

KILGORE COLLEGE ASSOCIATE DEGREE PROGRAM RNSG 1301 SYLLABUS PHARMACOLOGY. David Adamson, MSN, RN

Sublingual drug delivery system

Anemia and chronic kidney disease

Regulations for Handling Samples and Laboratory Testing from R&D through Phase III Clinical Trials

BIOTECHNOLOGY OPERATIONS

Microbiology and Auditing. Don Singer

Credit Suisse Healthcare Conference

Why Are Drugs So Expensive? Learning About the Drug Development Process

Generic Drug User Fee Act Program Performance Goals and Procedures

Goals & Objectives. Drug Development & the FDA Pharmacy 309. Outline. An History of Disasters. Be able to describe

CATEGORY Advertising. CATEGORY Biopharmaceutics. CATEGORY Biosimilarity

LIFE SCIENCE I TECHNICAL BULLETIN ISSUE N 11 /JULY 2008

Extemporaneously Prepared Early Phase Clinical Trial Materials

PHARMACEUTICAL DEVELOPMENT

Guidance for Industry ANDAs: Stability Testing of Drug Substances and Products

Public Assessment Report Scientific discussion. Tenofovir disoproxil Teva (tenofovir disoproxil) SE/H/1432/01/DC

Medication Utilization. Understanding Potential Medication Problems of the Elderly

Session 6: WHO Prequalification Programme. Key Process Steps WHO: Medicines UNFPA: Condoms and IUDs

CSAC/EIA Health Small Group Access+ HMO 15-0 Inpatient Benefit Summary

Working together for healthier living

Annual Report on Form 20-F

AMBERLITE IRP64 Pharmaceutical Grade Cation Exchange Resin (Polacrilex Resin)

Public Assessment Report. Decentralised Procedure. CosmoCol Half 6.9 g, powder for oral solution CosmoCol Paediatric 6.9 g, powder for oral solution

How To Stop Smoking. Tamra Casper

Summary Public Assessment Report. Generics. Amoxicilina + Ácido Clavulânico Ranbaxy,

Overview of Dissolution for BA/BE

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol

EXIGENCIA DE ESTUDIOS DE BIOEQUIVALENCIA A TRAVÉS DE METODOS IN VITRO

Pharmaceutical Sciences

Medication Aide Program. Medication Aide Program. Medication Aide Program. Ohio Assisted Living Association

Combination Products Regulation in the United States

NEUROTONE THR 00904/0005 UKPAR

PUBLIC ASSESSMENT REPORT Scientific Discussion. Perindopril arginine Amlodipine FR/H/ /01-04/DC. Applicant: Servier

Outsourcing in Drug Development From the Bench to the Market. Steven A. Kates, PhD Ischemix LLC

POLICY AND PROCEDURES OFFICE OF NEW DRUGS. Good Review Practice: Management of Breakthrough Therapy-Designated Drugs and Biologics.

Guidance for Industry

Basic Overview of Preclinical Toxicology Animal Models

Drug Excretion. Renal Drug Clearance. Drug Clearance and Half-Life. Glomerular Filtration II. Glomerular Filtration I. Drug Excretion and Clearance

Transcription:

Introduction to pharmaceutical technology Marie Wahlgren Chapter 1 What is the topics of today Introduction to the course Introduction to the project assignment How to choose a new drug formulation 1

Contacts and other important information Marie Wahlgren Marie.Wahlgren@food.lth.se 0702-216689 Department of food technology house V floor +1 Secretary Aniko Wolf Webpage www.food.lth.se What I want you to learn during this course Basic knowledge of pharmaceutical formulations How to evaluate the uptake of pharmaceutical components by the body The language used within the pharmaceutical industry The quality systems used by the pharmaceutical industry How to use all you already know about chemistry, biochemistry and chemical engineering in the field of drug product development 2

Course literature etc Aulton: Pharmaceutics The Science of Dosage Form Design A binder containing all the course SOPs and all the materials from my lectures The webpage of the course which includes All the material in the binder Links to other homepages Templates for reports etc. The course is in English I want you to think about whether this changes your learning tactics Do not hesitate to ask questions if you did not understood something during a lecture If you don t know the Swedish word for any of the things I talk about, ask As a help to you I will normally end every power point presentation with a list of important words. These are also listed on the webpage of the course. 3

Development of a drug product - What will be taken up in the course Preformulation Stability inv. Pharmacokinetics Stability inv Discovery Pre-clinical development IND Clinical I II III NDA Registration Formulation dev. Process development Packaging dev Quality demands that mimic those used in the industry Why To understand that the quality systems used in the pharmaceutical industry is part of becoming a pharmaceutical engineer It is an advantage to be familiar with them when you start to work in the industry Used in a sensible way they do improve your way of working How We use SOPs to describe different parts of the course. Laboratory work is documented according to standards used in the industry Lectures will be given on such issues as that of validation You ll be training on how to write specifications and production masters 4

Changes in the course from last year It will be an oral exam not a written one I have changed the assignment to reduce the amount of work I have changed some lectures There are two versions of the hand outs Oral exam Individual On your own questions You decide which grade you aim for Tomorrow we will train on writing questions 5

Oral exam Grade Criteria for grade 5 Questions that show that the student is able to have a deep understanding of important and complex concepts within the area of pharmaceutical technology 4 Questions that show that the student is able to link several important aspects of the course material to each other 3 Questions that require a basic understanding of important concepts Unaccept able Questions that only require one simple fact based answer Exercises and laborative work Two laboratory exercises (Introduction tomorrow at 13.15) Production of tablets Determination of log P or solubility One project assignment Two exercises to be carried out in seminar form 6

Project assignment Describe the development of a drug product in three stages Choice of a drug formulation Description of the disease,the drug substance and the drug product Description of the production process and of critical points for validation Starting point: description in article of an active substance Groups of 4-5 persons The assignment is described in SOP-2002.05 Part 1 Choose a route of delivery and suggest a suitable drug formulation (for example tablet, capsule or gel) Be prepared to discuss your choice of product next Monday. Start now by reading the SOP. During the break you can choose an article and group, or you can sign up during today or tomorrow. List on my door at the Department of Food Technology 7

Any questions on the project assignment? What is pharmaceutical development? It is the road from active substance to a finished product in its primary packing material. This includes functional production methods and all necessary documentation 8

OR FDA s definition The aim of pharmaceutical development is to design a quality product and its manufacturing process to consistently deliver the intended performance of the product. Why is formulation necessary Convenient To give the correct dose Protect the substance Alters the pharmacokinetic behaviour of the drug 9

What determines the choice of formulation? Patient Child, adult or elderly person Other diseases Culture and habits Doctors or society Price Tradition Insurance system Disease Acute, long term or chronic. How serious the disease is. Local or systemic treatment. Self-treatment or treatment by healthcare professionals. 10

The active substance Behaviour in vivo Uptake Metabolism prior to uptake, the first-pass effects Clearance Stability in vitro Interactions with excipients and packing material Sensitivity to moisture oxygen etc Physical and chemical properties Solubility Particle size Delivery routs Oral Injection Lungs Nasal mucosa Topical Rectum Vaginal Ophthalmic 11

Delivery routes a brief guide Formulation First pass effects Other enzymatic effects Absorption Other comments Oral yes yes Large area, active transport Most common Injection no no IV 100% Low patient compliance Inhalation no yes Large area Good adsorption Difficult regulatory demands Nasal no yes Small area High clearance Can reach the brain Topical no yes No active transport low permeability Local delivery Controlled release Rectal no Some but small Small area low permeability Good for children Choice of a formulation Primary concerns Desired pharmacokinetic profile Toxicity issues Patient compliance Properties of active substance Solubility Stability in vitro and in vivo Secondary concerns Price Time to market Available facilities The companies formulation platforms Patents 12

Common drug formulations 1% 1% 13% 15% 3% 3% 2% 16% 46% Tablets Liquid oral Capsules Injections Supposetories Topical Occular Aerosols Others General rule Keep it simple, stupid, If a simple fast-release tablet does the job, use it. Use approved excipients (excipient = all ingredients except the active substance) 13

Terms to know from today's lecture IND: Investigational New Drug NDA: New Drug Application The milestones in drug development where authorities are contacted SOP standard operating procedure: written instructions First pass effect: the drug is metabolised in the liver before reaching the blood In-vitro: conducted in a glass contaner in contrast to in-vivo where the experiment is done on living organisms I.V intravenous- injection into the veins Topical: on the skin 14